Outset Medical
99 hedge funds and large institutions have $57.3M invested in Outset Medical in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 24 closing their positions.
61% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 23
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 24
1% less capital invested
Capital invested by funds: $58.1M → $57.3M (-$765K)
1% less funds holding
Funds holding: 100 → 99 (-1)
4.44% less ownership
Funds ownership: 85.7% → 81.27% (-4.4%)
85% less call options, than puts
Call options by funds: $395K | Put options by funds: $2.66M
Top Buyers
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$5.57M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.57M |
| 3 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
+$822K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$735K |
| 5 |
Renaissance Technologies
New York
|
+$725K |
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$5.99M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$4.24M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$634K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$604K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$439K |
OM Hedge Fund Activity: Q1 2026 in Review
99 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q1 2026, worth a combined $57.3M — down 1.3% from $58.1M a quarter earlier.
Fund positioning in OM was balanced in Q1 2026: 24 funds opened new positions, 24 closed out, 37 added to existing stakes and 23 trimmed.
The largest buyer was BML Capital Management, adding an estimated $5.57M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $5.99M sold.
- 99 institutional investors held Outset Medical (OM) as of Q1 2026, down from 100 in Q4 2025.
- Funds reported $57.3M of Outset Medical stock for Q1 2026, down 1.3% quarter-over-quarter.
- 24 funds opened new Outset Medical positions in Q1 2026 and 24 closed out, a net change of 0 holders.
- The largest Outset Medical buyer in Q1 2026 was BML Capital Management, an estimated $5.57M added.
- The largest Outset Medical seller in Q1 2026 was Alyeska Investment Group, an estimated $5.99M sold.
Based on aggregated 13F filings for Q1 2026.